1.5T Intraoperative MR Imaging in Craniopharyngiomas

Sponsor
Hofmann, Bernd, M.D. (Other)
Overall Status
Completed
CT.gov ID
NCT01206543
Collaborator
(none)
25
1
1
52
0.5

Study Details

Study Description

Brief Summary

Purpose of this study is to investigate whether intraoperative imaging using a 1.5T MRI in craniopharyngioma surgery is useful in order to increase the rate of complete tumor removal.

Condition or Disease Intervention/Treatment Phase
  • Other: Intraoperative imaging using 1.5T MRI
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Intraoperative Use of a MR Tomography System Combined With Neuronavigation - Analysis of the Craniopharyngioma Subgroup ("Intraoperative Nutzung Eines Kernspintomographie-Systems in Direkter Kopplung Mit Einem Neuronavigations-System")
Study Start Date :
Apr 1, 2002
Actual Primary Completion Date :
Sep 1, 2005
Actual Study Completion Date :
Aug 1, 2006

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intraoperative imaging

Other: Intraoperative imaging using 1.5T MRI
Intraoperative imaging and determination of degree of resection / complete tumor removal

Outcome Measures

Primary Outcome Measures

  1. Rate of additional tumor removal [up to 3-4 months following surgery]

    Number of patients in whom non suspected tumor remants were indicated by intraoperative MRI and remnants could be removed completely thereafter. Results have to be confirmed in 1st follow up imaging.

  2. Rate of achievement of intended extent of removal [up to three months following surgery]

    It is examined whether the extent of tumor removal defined prior to surgery was achieved

  3. Diagnostic reliability [within 3 -4 months following surgery]

    false positive or negative interpretation of intraoperative imaging determined after follow-up imaging 3 - 4 months following surgery

Secondary Outcome Measures

  1. Surgical complication [within 1st week following surgery]

    Rate of new deficits following surgery (excluding new endocrine deficits)

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 75 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • complex craniopharyngioma > 1cm extension within 2 or more cranial fossae or ventricular system

  • Patient or legal representative able to provide written informed consent

Exclusion Criteria:
  • tumor size< 1 cm

  • Patients with any condition considered a contraindication to MRI

  • Patients with any condition considered a contraindication for surgery

  • Hypothalamic disturbances

  • Hypothalamic edema

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Neurosurgery University of Erlangen Erlangen Germany 91052

Sponsors and Collaborators

  • Hofmann, Bernd, M.D.

Investigators

  • Principal Investigator: Bernd Hofmann, MD,

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01206543
Other Study ID Numbers:
  • Cranio 15
First Posted:
Sep 22, 2010
Last Update Posted:
Sep 22, 2010
Last Verified:
Sep 1, 2010
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 22, 2010